Novellus

1 stories about Novellus
default image

Biological cancer treatment company Novellus raises $57 million

22.09.20|Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1